VAPOVAC™ : new FDA compliant H2O2 sterilisation system for pharmaceutical Lyophilizers
VAPOVAC™ the latest technology for H2O2 gas sterilisation of pharmaceutical freeze dryers from GEA Lyophil, has recently received a Letter of Non-Objection from the US Food and Drugs Administration (FDA).The FDA Letter of Non-Objection has now cleared the way for GEA Lyophil to market the VAPOVAC™ system worldwide. The system is ideally suited to pharmaceutical applications that require sterile conditions without the stresses and high power usage associated with steam sterilisation techniques.
For many years pharmaceutical freeze dryers have been fitted with SIP systems, (Sterilisation in Place) that use steam as the sterilising medium. However, steam sterilisation subjects the dryer to extreme ranges of pressure and temperature that the chamber, condenser and related piping must be built to withstand.
With VAPOVAC™, GEA Lyophil has developed a less expensive option using H2O2
(Hydrogen Peroxide) that is faster, safer, more efficient and easier on the environment than steam. The technology is available both for new plants and as a retrofit for existing installations.
The VAPOVAC™ steriliser uses VHP hydrogen peroxide to sterilise equipment under vacuum in a three-stage process: drying, sterilisation and aeration. Only a very small quantity of hydrogen peroxide is used to penetrate the freeze dryer vessels and all associated piping of the equipment. This method effectively eliminates all residual contamination. The freeze dryer is then fully vented, leaving no harmful residues.
GEA Lyophil is the only company to offer this technology. Hubert Kluetsch, Director of Sales and Marketing for the company, said that the FDA approval was very important. "Not having the FDA acceptance has held us back until now as so many potential customers were unable to consider technology that did not have the FDA stamp," he said. "Now that the FDA has given VAPOVAC™ its seal of approval, many new markets will be open for us."
VAPOVAC™ is just one of the freeze drying products supplied by GEA Lyophil for the pharmaceutical industry. The full range include: laboratory freeze dryers, both pilot scale for R&D and small production batches; industrial freeze dryers; and complete freeze dryer systems with Automatic Loading and Unloading Systems (ALUS®), integrated isolators, and CIP/SIP skids.
GEA Lyophil GmbH is part of the GEA Group and a specialist in freeze drying for the pharmaceutical industry
Steve Jordan - The Words Workshop Ltd.
26 Swanwick Lane, Milton Keynes, MK10 9LD, England.
Tel: (44) (0) 1908 695500 Fax: (44) (0) 1908 690099
mailto:steve@thewordsworkshop.co.uk
http://www.thewordsworkshop.co.uk
For further business information contact:
Hubert Kluetsch - Director Sales and Marketing
GEA Lyophil GmbH
Kalscheurener Str. 92, 50354 Huerth, Germany
Tel: +49 (0) 2233/6999-220 Fax: +49 (0) 2233/6999-8220
mailto:lyophil@geagroup.com
http://www.geapharmasystems.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release VAPOVAC™ : new FDA compliant H2O2 sterilisation system for pharmaceutical Lyophilizers here
News-ID: 169657 • Views: …
More Releases from GEA Lyophil GmbH
LYOPLUS® – multipurpose measurement device for pharmaceutical freeze dryers f …
One of the world’s biggest pharmaceutical companies has recently embarked on a long-term evaluation programme for the LYOPLUS® mass spectrometer from GEA Lyophil to provide essential data from within the freeze dryer itself. The company has confirmed a number of benefits of the LYOPLUS® system including: the ability to detect very small silicone oil leaks inside the dryer; the ability to monitor the moisture content within the freeze drying…
Visitors from around the world attend GEA Lyophil open-house seminars during Int …
Visitors to the Interpack 2011 exhibition in Dϋsseldorf were given the opportunity to attend a series of special in-house seminars presented by pharmaceutical freeze dryer manufacturer GEA Lyophil. The theme of the seminars held on May 13, 14 and 17 was ‘total cost of ownership’ and focused on the reduction of direct and indirect costs in relation to the freeze drying process.
Fifty delegates from 18 countries attended the seminars at…
More Releases for FDA
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…